Investment6 Nov 2025, 04:40 pm
GlaxoSmithKline Pharmaceuticals Invests in Solar Power Project for Nashik Plant
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd. has approved an investment of Rs. 1.74 crores for a Solar Power project for its plant at Nashik. The project is set up under the Group Captive mechanism to meet the company's green energy needs, optimize energy costs, and comply with regulatory requirements. Clean Max Galapagos Private Limited, a special purpose vehicle, will supply 4.95 MWp capacity to GlaxoSmithKline Pharmaceuticals Limited.
Key Highlights
- Investment of Rs. 1.74 crores for Solar Power project
- Project set up under Group Captive mechanism
- Meeting green energy needs and regulatory compliance
- Clean Max Galapagos Private Limited to supply 4.95 MWp capacity
- Incorporated on 21st May 2024